BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brégeon J, Neunlist M, Bossard C, Biraud M, Coron E, Bourreille A, Meurette G. Improvement of Refractory Ulcerative Proctitis With Sacral Nerve Stimulation. J Clin Gastroenterol 2015;49:853-7. [PMID: 25930972 DOI: 10.1097/MCG.0000000000000331] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Rosso C, Aaron AA, Armandi A, Caviglia GP, Vernero M, Saracco GM, Astegiano M, Bugianesi E, Ribaldone DG. Inflammatory Bowel Disease Nurse-Practical Messages. Nurs Rep 2021;11:229-41. [PMID: 34968201 DOI: 10.3390/nursrep11020023] [Reference Citation Analysis]
2 Zhang SH, Chen Y. Progress in research of sacral nerve stimulation. Shijie Huaren Xiaohua Zazhi 2020; 28(24): 1266-1271 [DOI: 10.11569/wcjd.v28.i24.1266] [Reference Citation Analysis]
3 Moore CK, Rueb JJ, Derisavifard S. What Is New in Neuromodulation? Curr Urol Rep 2019;20:55. [PMID: 31388779 DOI: 10.1007/s11934-019-0920-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
4 Nigam GB, Limdi JK, Vasant DH. Current perspectives on the diagnosis and management of functional anorectal disorders in patients with inflammatory bowel disease. Therap Adv Gastroenterol. 2018;11:1756284818816956. [PMID: 30574193 DOI: 10.1177/1756284818816956] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
5 Spear ET, Mawe GM. Enteric neuroplasticity and dysmotility in inflammatory disease: key players and possible therapeutic targets. Am J Physiol Gastrointest Liver Physiol 2019;317:G853-61. [PMID: 31604034 DOI: 10.1152/ajpgi.00206.2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
6 Michalopoulos G, Karmiris K. When disease extent is not always a key parameter: Management of refractory ulcerative proctitis. Curr Res Pharmacol Drug Discov 2022;3:100071. [PMID: 34988432 DOI: 10.1016/j.crphar.2021.100071] [Reference Citation Analysis]
7 Ramadi KB, Srinivasan SS, Traverso G. Electroceuticals in the Gastrointestinal Tract. Trends Pharmacol Sci 2020;41:960-76. [PMID: 33127099 DOI: 10.1016/j.tips.2020.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Stakenborg N, Boeckxstaens GE. Bioelectronics in the brain-gut axis: focus on inflammatory bowel disease (IBD). Int Immunol 2021;33:337-48. [PMID: 33788920 DOI: 10.1093/intimm/dxab014] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Barros LL, Farias AQ, Rezaie A. Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment. World J Gastroenterol 2019; 25(31): 4414-4426 [PMID: 31496621 DOI: 10.3748/wjg.v25.i31.4414] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]